Clinical Trials Logo

Clinical Trial Summary

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of problematic chemsex.


Clinical Trial Description

After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry. Patients who meet eligibility requirements will receive psychological intervention consisting in an 8-session individual on line-delivered ACT-based treatment. The participants will be assessed through self-report instruments before and after treatment and at 3 months follow-up. The clinical trial will include a control group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06406296
Study type Interventional
Source Universidad Europea de Madrid
Contact Francisco Montesinos, Ph.D.
Phone +34647413773
Email francisco.montesinos@universidadeuropea.es
Status Not yet recruiting
Phase N/A
Start date June 1, 2024
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT00467558 - Double-Blind Naltrexone in Compulsive Sexual Behavior Phase 2
Recruiting NCT06408545 - Acceptance and Commitment Therapy for Problematic Chemsex N/A
Enrolling by invitation NCT04634175 - Mind-body Intervention for Compulsive Sexual Behavior Disorder N/A
Completed NCT05572372 - Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality N/A
Completed NCT02300051 - Intervention Study for Individuals With Compulsive Sexual Behavior N/A
Completed NCT03495414 - Neurobiological Underpinnings to Hypersexual Disorder